887942261	887942261	CD	B-NP	O
|	|	NN	I-NP	O
TCUOMC	TCUOMC	NN	I-NP	O
|	|	NN	I-NP	O
21153172	21153172	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
2896037	2896037	CD	B-NP	O
|	|	CC	I-NP	O
7/25/2005	7/25/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
SYNCOPE	SYNCOPE	NNP	I-NP	O
,	,	,	O	O
LEFT	LEFT	NNP	B-NP	O
SHOULDRE	SHOULDRE	NNP	I-NP	O
FRACTURE	FRACTURE	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/25/2005	7/25/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/2/2005	1/2/2005	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
MACHI	MACHI	NNP	B-NP	O
,	,	,	O	O
COLTON	COLTON	NNP	B-NP	O
MD	MD	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	NNP	B-NP	O
ILLNESS	ILLNESS	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
68-year-old	68-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
insulin-dependent	insulin-dependent	JJ	B-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
hyperlipidemia	hyperlipidemia	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
known	known	JJ	I-NP	O
EF	EF	NN	I-NP	O
of	of	IN	B-PP	O
25	25	CD	B-NP	O
to	to	TO	I-NP	O
30	30	CD	I-NP	O
%	%	NN	I-NP	O
and	and	CC	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
Graves	Graves	NN	B-NP	O
disease	disease	NN	I-NP	O
who	who	WP	B-NP	O
presents	present	VBZ	B-VP	O
to	to	TO	B-PP	O
us	us	PRP	B-NP	O
after	after	IN	B-PP	O
a	a	DT	B-NP	O
fall	fall	NN	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
chief	chief	JJ	I-NP	O
complaint	complaint	NN	I-NP	O
of	of	IN	B-PP	O
left	left	JJ	B-NP	B-protein
shoulder	shoulder	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
states	state	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
slight	slight	JJ	I-NP	O
headache	headache	NN	I-NP	O
and	and	CC	I-NP	O
dizziness	dizziness	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
felt	feel	VBD	B-VP	O
better	well	RBR	B-ADVP	O
after	after	IN	B-PP	O
eating	eat	VBG	B-VP	O
breakfast	breakfast	NN	B-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
approaching	approach	VBG	I-VP	O
her	her	PRP$	B-NP	O
daughter	daughter	NN	I-NP	O
,	,	,	O	O
answered	answer	VBD	B-VP	O
the	the	DT	B-NP	O
doorbell	doorbell	NN	I-NP	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
fell	fall	VBD	B-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
associated	associate	VBN	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
lightheadedness	lightheadedness	NN	B-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
vomiting	vomiting	NN	B-NP	O
,	,	,	O	O
warmth	warmth	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
states	state	VBZ	B-VP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
wearing	wear	VBG	I-VP	O
shoes	shoe	NNS	B-NP	O
,	,	,	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
believe	believe	VB	I-VP	O
she	she	PRP	B-NP	O
tripped	trip	VBD	B-VP	O
.	.	.	O	O

No	No	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
seizure	seizure	NN	B-NP	O
activity	activity	NN	I-NP	O
,	,	,	O	O
postictal	postictal	JJ	B-NP	O
state	state	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
loss	loss	NN	B-NP	O
of	of	IN	B-PP	O
bowel	bowel	NN	B-NP	O
or	or	CC	I-NP	O
bladder	bladder	NN	I-NP	O
incontinence	incontinence	NN	I-NP	O
.	.	.	O	O

After	After	IN	B-PP	O
the	the	DT	B-NP	O
fall	fall	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
complained	complain	VBD	B-VP	O
of	of	IN	B-PP	O
left	left	JJ	B-NP	B-protein
shoulder	shoulder	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
with	with	IN	B-PP	O
movement	movement	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
denies	deny	VBZ	B-VP	O
loss	loss	NN	B-NP	O
of	of	IN	B-PP	O
consciousness	consciousness	NN	B-NP	O
,	,	,	O	O
head	head	NN	B-NP	O
trauma	trauma	NN	I-NP	O
.	.	.	O	O

Started	Start	VBD	B-VP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
medication	medication	NN	I-NP	O
,	,	,	O	O
gabapentin	gabapentin	NN	B-NP	B-protein
,	,	,	O	O
this	this	DT	B-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
fracture	fracture	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
left	left	JJ	I-NP	O
surgical	surgical	JJ	I-NP	O
humeral	humeral	JJ	I-NP	O
neck	neck	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
Tylenol	Tylenol	NN	B-NP	O
and	and	CC	I-NP	O
Toradol	Toradol	NN	I-NP	O
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
.	.	.	O	O

CAT	CAT	NN	B-NP	B-protein
scan	scan	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
events	event	NNS	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Significant	Significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
insulin-dependent	insulin-dependent	JJ	B-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
A1c	A1c	NN	I-NP	O
of	of	IN	B-PP	O
11.9	11.9	CD	B-NP	O
,	,	,	O	O
known	know	VBN	B-NP	O
retinopathy	retinopathy	NN	I-NP	O
and	and	CC	I-NP	O
neuropathy	neuropathy	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
hypertensive	hypertensive	JJ	B-NP	O
encephalopathy	encephalopathy	NN	I-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
Graves	Graves	NN	B-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
CHF	CHF	NN	B-NP	B-protein
,	,	,	O	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
known	known	JJ	I-NP	O
EF	EF	NN	I-NP	O
of	of	IN	B-PP	O
25	25	CD	B-NP	O
to	to	TO	I-NP	O
30	30	CD	I-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
concentric	concentric	JJ	B-NP	O
LVH	LVH	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
pulmonary	pulmonary	JJ	B-NP	O
pressures	pressure	NNS	I-NP	O
of	of	IN	B-PP	O
52	52	CD	B-NP	O
plus	plus	CC	O	O
right	right	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
,	,	,	O	O
dermatomyositis	dermatomyositis	NN	B-NP	O
,	,	,	O	O
arthritis	arthritis	NN	B-NP	O
,	,	,	O	O
cataracts	cataract	NNS	B-NP	O
,	,	,	O	O
B12	B12	NN	B-NP	B-protein
diffeciency	diffeciency	NN	I-NP	O
,	,	,	O	O
stress	stress	NN	B-NP	O
urinary	urinary	JJ	I-NP	O
incontinence	incontinence	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	VBD	B-VP	O
total	total	JJ	B-NP	O
abdominal	abdominal	JJ	I-NP	O
hysterectomy	hysterectomy	NN	I-NP	O
,	,	,	O	O
bilateral	bilateral	JJ	B-NP	O
salpingo-oophorectomy	salpingo-oophorectomy	NN	I-NP	O
,	,	,	O	O
previous	previous	JJ	B-NP	O
syncopal	syncopal	JJ	I-NP	O
episode	episode	NN	I-NP	O
in	in	IN	B-PP	O
2001	2001	CD	B-NP	O
where	where	WRB	B-ADVP	O
she	she	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
Bruce	Bruce	NNP	I-NP	O
protocol	protocol	NN	I-NP	O
,	,	,	O	O
stress	stress	NN	B-NP	O
maybe	maybe	RB	B-ADVP	O
with	with	IN	B-PP	O
poor	poor	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
tolerance	tolerance	NN	I-NP	O
with	with	IN	B-PP	O
50	50	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	O	O
stopped	stop	VBD	B-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-VP	O
fatigue	fatigue	VB	I-VP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
allergic	allergic	JJ	B-ADJP	O
to	to	TO	B-PP	O
penicillin	penicillin	NN	B-NP	B-protein
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
,	,	,	O	O
codeine	codeine	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
simvastatin	simvastatin	NN	B-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Include	Include	VBP	B-VP	O
metformin	metformin	NN	B-NP	O
400	400	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
insulin	insulin	NN	B-NP	B-protein
80	80	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
subcutaneously	subcutaneously	RB	B-ADVP	O
q.h.s.	q.h.s.	RB	I-ADVP	O
,	,	,	O	O
atenolol	atenolol	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
,	,	,	O	O
hydrochlorothiazide	hydrochlorothiazide	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
,	,	,	O	O
Vasotec	Vasotec	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
,	,	,	O	O
pravastatin	pravastatin	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
,	,	,	O	O
Neurontin	Neurontin	NN	B-NP	B-protein
300	300	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
t.i.d.	t.i.d.	NN	I-NP	I-protein
,	,	,	O	O
amitriptyline	amitriptyline	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
folate	folate	VB	B-VP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
lives	live	VBZ	B-VP	O
alone	alone	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
floor	floor	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
apartment	apartment	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
stairs	stair	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
30-pack-year	30-pack-year	JJ	I-NP	O
smoker	smoker	NN	I-NP	O
,	,	,	O	O
quit	quit	VBD	B-VP	O
approximately	approximately	RB	B-NP	O
30	30	CD	I-NP	O
years	year	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
.	.	.	O	O

No	No	DT	B-NP	O
alcohol	alcohol	NN	I-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
pertinent	pertinent	JJ	I-NP	O
family	family	NN	I-NP	O
history	history	NN	I-NP	O
.	.	.	O	O

REVIEW	REVIEW	NNP	B-NP	O
OF	OF	IN	B-PP	O
SYSTEMS	SYSTEMS	NNP	B-NP	O
:	:	:	O	O
Negative	Negative	JJ	B-ADJP	O
.	.	.	O	O

no	no	DT	B-NP	O
fever	fever	NN	I-NP	O
,	,	,	O	O
chills	chill	NNS	B-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
vomiting	vomiting	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
changes	change	NNS	B-NP	O
in	in	IN	B-PP	O
appetite	appetite	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
bright	bright	JJ	I-NP	O
red	red	JJ	I-NP	O
blood	blood	NN	I-NP	O
per	per	IN	B-PP	O
rectum	rectum	NN	B-NP	O
or	or	CC	O	O
black	black	JJ	B-NP	O
tarry	tarry	NN	I-NP	O
stools	stool	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
cough	cough	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dysuria	dysuria	NN	I-NP	O
or	or	CC	O	O
urinary	urinary	JJ	B-NP	O
frequency	frequency	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
constipation	constipation	NN	I-NP	O
or	or	CC	I-NP	O
diarrhea	diarrhea	NN	I-NP	O
.	.	.	O	O

ADMISSION	ADMISSION	NN	B-NP	O
PHYSICAL	PHYSICAL	NN	I-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
.	.	.	O	O

Heart	Heart	NN	B-NP	O
rate	rate	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
50s	50	NNS	I-NP	O
.	.	.	O	O

BP	BP	NN	B-NP	O
130/70	130/70	CD	I-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
16	16	CD	I-NP	O
,	,	,	O	O
satting	satte	VBG	B-VP	O
99	99	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
,	,	,	O	O
pleasant	pleasant	NN	B-NP	O
,	,	,	O	O
complaining	complain	VBG	B-VP	O
of	of	IN	B-PP	O
left	left	JJ	B-NP	B-protein
arm	arm	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
with	with	IN	B-PP	O
movement	movement	NN	B-NP	O
.	.	.	O	O

Mucous	Mucous	JJ	B-NP	O
membranes	membrane	NNS	I-NP	O
are	be	VBP	B-VP	O
moist	moist	JJ	B-ADJP	O
.	.	.	O	O

No	No	DT	B-NP	O
lymphadenopathy	lymphadenopathy	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
thyromegaly	thyromegaly	NN	I-NP	O
.	.	.	O	O

Oropharynx	Oropharynx	NNP	B-NP	O
is	be	VBZ	B-VP	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

Chest	Chest	NNP	B-NP	O
is	be	VBZ	B-VP	O
clear	clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
aside	aside	RB	I-ADVP	O
from	from	IN	B-PP	O
some	some	DT	B-NP	O
bilateral	bilateral	JJ	I-NP	O
wheezes	wheeze	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
bases	base	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
bradycardic	bradycardic	JJ	B-ADJP	O
.	.	.	O	O

S1	S1	NN	B-NP	B-protein
and	and	CC	I-NP	O
S2	S2	NN	I-NP	B-protein
.	.	.	O	O

Distant	Distant	JJ	B-NP	O
heart	heart	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
,	,	,	O	O
gallops	gallop	NNS	B-NP	O
,	,	,	O	O
or	or	CC	O	O
rubs	rub	NNS	B-NP	O
appreciated	appreciate	VBN	B-VP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
is	be	VBZ	B-VP	O
obese	obese	JJ	B-ADJP	O
.	.	.	O	O

Soft	Soft	RB	B-ADVP	O
,	,	,	O	O
nontender	nontender	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
nondistended	nondistended	JJ	B-ADJP	O
.	.	.	O	O

Positive	Positive	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
exam	exam	VBP	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
left	left	JJ	B-NP	O
shoulder	shoulder	NN	I-NP	O
extreme	extreme	JJ	I-NP	O
tenderness	tenderness	NN	I-NP	O
to	to	TO	B-PP	O
palpation	palpation	NN	B-NP	O
and	and	CC	I-NP	O
movement	movement	NN	I-NP	O
with	with	IN	B-PP	O
noticeable	noticeable	JJ	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

Pulses	Pulse	NNS	B-NP	O
are	be	VBP	B-VP	O
intact	intact	JJ	B-ADJP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Skin	Skin	NNP	B-NP	O
is	be	VBZ	B-VP	O
clean	clean	JJ	B-ADJP	O
,	,	,	O	O
dry	dry	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

No	No	DT	B-NP	O
rashes	rash	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
alert	alert	JJ	B-NP	O
and	and	CC	I-NP	O
oriented	orient	VBN	I-NP	O
x3	x3	NN	I-NP	O
.	.	.	O	O

Cranial	Cranial	NNP	B-NP	O
nerves	nerve	VBZ	B-VP	O
II	II	CD	B-NP	O
through	through	IN	B-PP	O
XII	XII	NN	B-NP	B-DNA
are	be	VBP	B-VP	O
grossly	grossly	RB	B-ADJP	O
intact	intact	JJ	I-ADJP	O
,	,	,	O	O
moving	move	VBG	B-VP	O
all	all	DT	B-NP	O
extremities	extremity	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
pronator	pronator	NN	I-NP	O
drift	drift	NN	I-NP	O
.	.	.	O	O

Reflexes	Reflex	NNS	B-NP	O
are	be	VBP	B-VP	O
symmetric	symmetric	JJ	B-ADJP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
Significant	Significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
potassium	potassium	NN	B-NP	O
of	of	IN	B-PP	O
5.8	5.8	CD	B-NP	O
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
of	of	IN	B-PP	O
1.0	1.0	CD	B-NP	O
,	,	,	O	O
0.8	0.8	CD	B-NP	O
baseline	baseline	NN	I-NP	O
.	.	.	O	O

WBC	WBC	NNP	B-NP	O
10	10	CD	I-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	O
34.5	34.5	CD	I-NP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
negative	negative	JJ	I-NP	O
x1	x1	NN	I-NP	O
.	.	.	O	O

TSH	TSH	NN	B-NP	O
of	of	IN	B-PP	O
27	27	CD	B-NP	O
,	,	,	O	O
T3	T3	NN	B-NP	O
109	109	CD	I-NP	O
,	,	,	O	O
T4	T4	NN	B-NP	B-cell_line
4.9	4.9	CD	I-NP	I-cell_line
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
is	be	VBZ	B-VP	O
clear	clear	JJ	B-ADJP	O
,	,	,	O	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
cardiomegaly	cardiomegaly	RB	B-NP	O
.	.	.	O	O

IMPRESSION	IMPRESSION	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
58-year-old	58-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
insulin-dependent	insulin-dependent	JJ	B-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
hyperlipidemia	hyperlipidemia	NN	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	O
of	of	IN	B-PP	O
25	25	CD	B-NP	O
to	to	TO	I-NP	O
30	30	CD	I-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
graves	grave	VBZ	B-VP	O
disease	disease	NN	B-NP	O
,	,	,	O	O
presents	present	VBZ	B-VP	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
fall	fall	NN	I-NP	O
,	,	,	O	O
denies	deny	VBZ	B-VP	O
loss	loss	NN	B-NP	O
of	of	IN	B-PP	O
consciousness	consciousness	NN	B-NP	O
.	.	.	O	O

Syncope	Syncope	NN	B-NP	O
workup	workup	NN	I-NP	O
in	in	IN	B-PP	O
?	?	.	O	B-cell_line
?	?	.	O	I-cell_line
___	___	''	O	I-cell_line
?	?	.	O	O
?	?	.	O	O
rule	rule	VBD	B-VP	O
out	out	RP	B-PRT	O
myocardial	myocardial	JJ	B-NP	O
infarction	infarction	NN	I-NP	O
,	,	,	O	O
arrhythmia	arrhythmia	NN	B-NP	O
,	,	,	O	O
cerebrovascular	cerebrovascular	JJ	B-NP	O
accident	accident	NN	I-NP	O
,	,	,	O	O
transient	transient	JJ	B-NP	O
ischemic	ischemic	JJ	I-NP	O
attacks	attack	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
left	left	JJ	B-NP	O
surgical	surgical	JJ	I-NP	O
humeral	humeral	JJ	I-NP	O
neck	neck	NN	I-NP	O
fracture	fracture	NN	I-NP	O
and	and	CC	O	O
positive	positive	JJ	B-NP	O
UA	UA	NN	I-NP	O
.	.	.	O	O

Etiology	Etiology	NN	B-NP	O
of	of	IN	B-PP	O
syncope	syncope	NN	B-NP	O
unclear	unclear	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
bradycardic	bradycardic	JJ	B-ADJP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
may	may	MD	B-VP	O
have	have	VB	I-VP	O
been	be	VBN	I-VP	O
over	over	IN	B-PP	O
beta-blocker	beta-blocker	NN	B-NP	O
,	,	,	O	O
also	also	RB	B-ADVP	O
with	with	IN	B-PP	O
positive	positive	JJ	B-NP	O
urinary	urinary	JJ	I-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
experienced	experience	VBD	B-VP	O
multiple	multiple	JJ	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
a.m.	a.m.	NN	B-NP	O
hyperglycemia	hyperglycemia	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
may	may	MD	B-VP	O
have	have	VB	I-VP	O
been	be	VBN	I-VP	O
contributing	contribute	VBG	I-VP	O
.	.	.	O	O

PLAN	PLAN	NNP	B-NP	O
BY	BY	NNP	I-NP	O
SYSTEMS	SYSTEMS	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	NNP	B-NP	O
:	:	:	O	O
A.	A.	NNP	B-NP	O
Ischemia	Ischemia	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
completed	complete	VBD	B-VP	O
a	a	DT	B-NP	O
complete	complete	JJ	I-NP	O
rule	rule	NN	I-NP	O
out	out	IN	B-PP	O
MI	MI	NN	B-NP	O
workup	workup	NN	I-NP	O
with	with	IN	B-PP	O
negative	negative	JJ	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
and	and	CC	O	O
no	no	DT	B-NP	O
EKG	EKG	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
beta-blocker	beta-blocker	NN	B-NP	O
,	,	,	O	O
ACE	ACE	NN	B-NP	O
inhibitor	inhibitor	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
statin	statin	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
aspirin	aspirin	NN	I-NP	O
given	give	VBN	B-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
allergy	allergy	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
repeat	repeat	NN	I-NP	O
echo	echo	NN	I-NP	O
on	on	IN	B-PP	O
May	May	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	B-protein
of	of	IN	B-PP	O
45	45	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	I-NP	O
mild	mild	JJ	I-NP	O
global	global	JJ	I-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
and	and	CC	O	O
left	leave	VBD	B-VP	O
atrial	atrial	JJ	B-NP	O
enlargement	enlargement	NN	I-NP	O
.	.	.	O	O

B.	B.	NNP	B-NP	O
Rhythm	Rhythm	NNP	I-NP	O
:	:	:	O	O
Significant	Significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
bradycardia	bradycardia	NN	B-NP	O
.	.	.	O	O

Lopressor	Lopressor	NN	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
inhouse	inhouse	NN	B-NP	O
in	in	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
better	well	RBR	I-VP	O
titrate	titrate	VB	I-VP	O
pulse	pulse	NN	B-NP	O
rate	rate	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
to	to	TO	B-PP	O
Coreg	Coreg	NN	B-NP	O
6.25	6.25	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
and	and	CC	O	O
titrated	titrate	VBN	B-VP	O
to	to	TO	B-PP	O
12	12	CD	B-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
well	well	RB	B-VP	O
tolerated	tolerate	VBN	I-VP	O
.	.	.	O	O

No	No	DT	B-NP	O
further	further	JJ	I-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
bradycardia	bradycardia	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
Baseline	Baseline	NN	B-NP	O
creatinine	creatinine	NN	I-NP	O
0.8	0.8	CD	I-NP	O
.	.	.	O	O

Creatinine	Creatinine	NN	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
1.0	1.0	CD	I-NP	O
,	,	,	O	O
remained	remain	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
,	,	,	O	O
no	no	DT	B-NP	O
issues	issue	NNS	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Infectious	Infectious	JJ	B-NP	O
Disease	Disease	NN	I-NP	O
:	:	:	O	O
Positive	Positive	JJ	B-NP	O
UA	UA	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

Completed	Complete	VBN	B-NP	O
3-day	3-day	JJ	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
ciprofloxacin	ciprofloxacin	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
chronic	chronic	JJ	I-NP	O
complaints	complaint	NNS	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Fluids	Fluid	NNS	B-NP	O
,	,	,	O	O
Electrolytes	Electrolyte	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Nutrition	Nutrition	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
ADA	ADA	NN	B-NP	B-protein
low-salt	low-salt	JJ	I-NP	O
cardiac	cardiac	JJ	I-NP	O
diet	diet	NN	I-NP	O
,	,	,	O	O
repeat	repeat	VB	B-VP	O
it	it	PRP	B-NP	O
with	with	IN	B-PP	O
potassium	potassium	NN	B-NP	O
and	and	CC	I-NP	O
magnesium	magnesium	NN	I-NP	O
scales	scale	NNS	I-NP	O
.	.	.	O	O

Hematocrit	Hematocrit	NN	B-NP	B-protein
remained	remain	VBD	B-VP	I-protein
low	low	JJ	B-ADJP	I-protein
at	at	IN	B-PP	I-protein
34.5	34.5	CD	B-NP	I-protein
,	,	,	O	O
but	but	CC	O	O
remained	remain	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
folate	folate	NN	B-NP	O
and	and	CC	I-NP	O
B12	B12	NN	I-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
continue	continue	VB	I-VP	O
workup	workup	NN	B-NP	O
of	of	IN	B-PP	O
anemia	anemia	NN	B-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Endocrine	Endocrine	JJ	B-ADVP	O
:	:	:	O	O
Initially	Initially	RB	B-NP	O
continued	continue	VBN	I-NP	O
Lantus	Lantus	NNP	I-NP	O
80	80	CD	I-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
q.h.s.	q.h.s.	VBP	B-VP	O
with	with	IN	B-PP	O
insulin	insulin	NN	B-NP	B-protein
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
a.m.	a.m.	NN	B-NP	O
hyperglycemia	hyperglycemia	NN	I-NP	O
,	,	,	O	O
changed	change	VBD	B-VP	O
Lantus	Lantus	NNP	B-NP	O
to	to	TO	B-PP	O
q.a.m.	q.a.m.	NN	B-NP	O
and	and	CC	O	O
added	add	VBD	B-VP	O
q.a.c.	q.a.c.	NN	B-NP	B-protein
short-acting	short-acting	JJ	I-NP	I-protein
insulin	insulin	NN	I-NP	I-protein
for	for	IN	B-PP	O
better	good	JJR	B-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
metformin	metformin	NN	B-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
inpatient	inpatient	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
PFTs	PFT	NNS	B-NP	B-protein
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
mild	mild	JJ	I-NP	O
hypothyroidism	hypothyroidism	NN	I-NP	O
with	with	IN	B-PP	O
low	low	JJ	B-NP	O
free	free	JJ	I-NP	O
T4	T4	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Synthroid	Synthroid	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
should	should	MD	B-VP	O
continue	continue	VB	I-VP	O
to	to	TO	I-VP	O
follow	follow	VB	I-VP	O
thyroid	thyroid	JJ	B-NP	O
function	function	NN	I-NP	O
tests	test	NNS	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

Orthopedic	Orthopedic	JJ	B-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
regarding	regard	VBG	B-PP	O
humerus	humerus	JJ	B-NP	O
fracture	fracture	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
splinted	splint	VBN	I-VP	O
by	by	IN	B-PP	O
Ortho	Ortho	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
should	should	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
in	in	IN	B-PP	O
clinic	clinic	NN	B-NP	O
as	as	IN	B-SBAR	O
indicated	indicate	VBN	B-VP	O
.	.	.	O	O

Pain	Pain	NN	B-NP	O
control	control	NN	I-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
given	give	VBN	I-VP	O
allergy	allergy	NN	B-NP	O
to	to	TO	B-PP	O
Codeine	Codeine	NN	B-NP	O
.	.	.	O	O

Trial	Trial	NN	B-NP	O
of	of	IN	B-PP	O
around	around	IN	B-PP	O
the	the	DT	B-NP	O
clock	clock	NN	I-NP	O
Tylenol	Tylenol	NN	I-NP	O
alternating	alternate	VBG	B-VP	O
with	with	IN	B-PP	O
Lidoderm	Lidoderm	NN	B-NP	O
patch	patch	NN	I-NP	O
were	be	VBD	B-VP	O
effective	effective	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
received	receive	VBD	B-VP	O
physical	physical	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
inpatient	inpatient	NN	I-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
benefit	benefit	VB	I-VP	O
from	from	IN	B-PP	O
continued	continue	VBN	B-NP	O
PT	PT	NN	I-NP	O
at	at	IN	B-PP	O
rehabilitation	rehabilitation	NN	B-NP	O
.	.	.	O	O

Followup	Followup	NN	B-NP	O
is	be	VBZ	B-VP	O
scheduled	schedule	VBN	I-VP	O
with	with	IN	B-PP	O
Ortho	Ortho	NNP	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
discharge	discharge	NN	I-NP	O
summary	summary	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
amitriptyline	amitriptyline	NN	B-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
for	for	IN	B-PP	O
prophylaxis	prophylaxis	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
Nexium	Nexium	NN	B-NP	O
and	and	CC	I-NP	O
Lovenox	Lovenox	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-ADJP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Tylenol	Tylenol	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
4h	4h	NN	I-NP	O
.	.	.	O	O

,	,	,	O	O
amitriptyline	amitriptyline	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.h.s.	q.h.s.	FW	I-NP	O
p.r.n.	p.r.n.	FW	I-NP	O
insomnia	insomnia	NN	I-NP	O
,	,	,	O	O
Dulcolax	Dulcolax	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	FW	I-NP	O
p.r.n.	p.r.n.	FW	I-NP	O
constipation	constipation	NN	I-NP	O
,	,	,	O	O
B12	B12	NN	B-NP	O
50	50	CD	I-NP	O
mcg	mcg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Vasotec	Vasotec	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
folate	folate	VB	B-VP	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
HCTZ	HCTZ	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
insulin	insulin	NN	B-NP	O
regular	regular	JJ	I-NP	O
sliding	slide	VBG	I-NP	O
scale	scale	NN	I-NP	O
q.a.c.	q.a.c.	NN	I-NP	O
,	,	,	O	O
lactulose	lactulose	RB	B-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.i.d.	q.i.d.	FW	I-NP	O
p.r.n.	p.r.n.	FW	I-NP	O
constipation	constipation	NN	I-NP	O
,	,	,	O	O
Synthroid	Synthroid	JJ	B-NP	O
50	50	CD	I-NP	O
mcg	mcg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
magnesium	magnesium	NN	B-NP	O
gluconate	gluconate	NN	I-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
,	,	,	O	O
milk	milk	NN	B-NP	O
of	of	IN	B-PP	O
magnesia	magnesia	NN	B-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
constipation	constipation	NN	I-NP	O
,	,	,	O	O
senna	senna	NN	B-NP	O
2	2	CD	I-NP	O
tablets	tablet	NNS	I-NP	O
p.o.	p.o.	FW	I-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
,	,	,	O	O
pravastatin	pravastatin	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
Neurontin	Neurontin	NN	B-NP	O
300	300	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
t.i.d.	t.i.d.	FW	I-ADVP	O
,	,	,	O	O
Imdur	Imdur	NNP	B-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Lovenox	Lovenox	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
q.d.	q.d.	RB	I-ADVP	O
,	,	,	O	O
Ultram	Ultram	NNP	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-LST	O
pain	pain	NN	B-NP	O
,	,	,	O	O
Coreg	Coreg	NN	B-NP	O
12.5	12.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Nexium	Nexium	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
insulin	insulin	NN	B-NP	B-protein
glargine	glargine	NN	I-NP	I-protein
80	80	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
subcutaneously	subcutaneously	RB	B-ADVP	O
q.a.m.	q.a.m.	RB	I-ADVP	O
,	,	,	O	O
Lidoderm	Lidoderm	NNP	B-NP	O
5	5	CD	I-NP	O
%	%	NN	I-NP	O
patch	patch	NN	I-NP	O
topical	topical	JJ	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
NovoLog	NovoLog	NN	B-NP	B-protein
4	4	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
subcutaneously	subcutaneously	RB	B-ADVP	O
a.c.	a.c.	VBP	B-VP	O
FOLLOWUP	FOLLOWUP	NN	B-NP	O
APPOINTMENTS	APPOINTMENTS	NNS	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
followup	followup	JJ	I-NP	O
appointment	appointment	NN	I-NP	O
with	with	IN	B-PP	O
Ortho	Ortho	NNP	B-NP	O
Trauma	Trauma	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
on	on	IN	B-PP	O
February	February	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
,	,	,	O	O
at	at	IN	B-PP	O
8	8	CD	B-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
.	.	.	O	O

After	After	IN	B-PP	O
discharge	discharge	NN	B-NP	O
from	from	IN	B-PP	O
RHAMC	RHAMC	NN	B-NP	B-protein
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
schedule	schedule	VB	I-VP	O
a	a	DT	B-NP	O
PCP	PCP	NN	I-NP	O
followup	followup	NN	I-NP	O
appointment	appointment	NN	I-NP	O
.	.	.	O	O

Any	Any	DT	B-NP	O
questions	question	NNS	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
answered	answer	VBN	I-VP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Dustin	Dustin	NNP	I-NP	O
Aulbach	Aulbach	NNP	I-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
7-6093331	7-6093331	CD	B-NP	O
SSSten	SSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
CC	CC	NNP	I-NP	O
:	:	:	O	O
Primary	Primary	NNP	B-NP	O
Care	Care	NNP	I-NP	O
Physician	Physician	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
MEDICH	MEDICH	NNP	B-NP	O
,	,	,	O	O
LUIGI	LUIGI	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
BOLICH	BOLICH	NN	B-NP	O
,	,	,	O	O
ERNIE	ERNIE	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
1134385	1134385	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
9/10/05	9/10/05	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
9/10/05	9/10/05	CD	B-NP	O

